These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23196444)

  • 21. Mechanism of the Nrf2/Keap1/ARE signaling system.
    Tkachev VO; Menshchikova EB; Zenkov NK
    Biochemistry (Mosc); 2011 Apr; 76(4):407-22. PubMed ID: 21585316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
    Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
    Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Keap1-Nrf2 system and diabetes mellitus.
    Uruno A; Yagishita Y; Yamamoto M
    Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers.
    Satoh T; Okamoto SI; Cui J; Watanabe Y; Furuta K; Suzuki M; Tohyama K; Lipton SA
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):768-73. PubMed ID: 16407140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Biochem Soc Trans; 2015 Aug; 43(4):645-9. PubMed ID: 26551706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward clinical application of the Keap1-Nrf2 pathway.
    Suzuki T; Motohashi H; Yamamoto M
    Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nrf2-Keap1 signaling in oxidative and reductive stress.
    Bellezza I; Giambanco I; Minelli A; Donato R
    Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):721-733. PubMed ID: 29499228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oxidative/electrophilic stress sensor Keap1 regulates the rapid turnover of transcripition factor Nrf2].
    Kobayashi A; Tong KI
    Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1304-8. PubMed ID: 16922392
    [No Abstract]   [Full Text] [Related]  

  • 30. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of oxidative stress by Nrf2 in the pathophysiology of infectious diseases.
    Deramaudt TB; Dill C; Bonay M
    Med Mal Infect; 2013 Mar; 43(3):100-7. PubMed ID: 23499316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice.
    Brachs S; Winkel AF; Polack J; Tang H; Brachs M; Margerie D; Brunner B; Jahn-Hofmann K; Ruetten H; Spranger J; Schmoll D
    PLoS One; 2016; 11(11):e0166110. PubMed ID: 27814396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
    Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
    FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.
    Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D
    Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts.
    Nordgren KK; Wallace KB
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):107-16. PubMed ID: 24211725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM; Kruszewski MK
    Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directly interact with Keap1 and LPS is involved in the anti-inflammatory mechanisms of (-)-epicatechin-3-gallate in LPS-induced macrophages and endotoxemia.
    Chiou YS; Huang Q; Ho CT; Wang YJ; Pan MH
    Free Radic Biol Med; 2016 May; 94():1-16. PubMed ID: 26878775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2.
    Cloer EW; Siesser PF; Cousins EM; Goldfarb D; Mowrey DD; Harrison JS; Weir SJ; Dokholyan NV; Major MB
    Mol Cell Biol; 2018 Nov; 38(22):. PubMed ID: 30126895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.